Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELRANATAMAB vs ELUXADOLINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELRANATAMAB vs ELUXADOLINE: Safety Overview

Metric ELRANATAMAB ELUXADOLINE
Total FAERS Reports 758 2,353
Deaths Reported 177 37
Death Rate 23.4% 1.6%
Hospitalizations 482 413
Average Patient Age 67.6 yrs 57.4 yrs
% Female Patients 45.2% 77.7%
FDA Approval Date N/A Mar 14, 2025
Manufacturer Pfizer Laboratories Div Pfizer Inc Allergan, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription